BTK-IN-9

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

BTK-IN-9 

BTK-IN-9 是一种可逆的 BTK 抑制剂,在套细胞淋巴瘤细胞中中具有较强的抗增殖活性。BTK-IN-9 特异性地扰乱线粒体膜电位并增加 Z138 细胞中的活性氧水平。BTK-IN-9 还诱导 Z138 细胞中的细胞凋亡。

BTK-IN-9

BTK-IN-9 Chemical Structure

CAS No. : 2361192-21-2

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

BTK-IN-9 is a reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma. BTK-IN-9 specifically disturbs mitochondrial membrane potential and increases reactive oxygen species level in Z138 cells. BTK-IN-9 also induces cell apoptosis in Z138 cells[1].

分子量

481.46

Formula

C25H19N7O4

CAS 号

2361192-21-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Ran F, et al. Design and synthesis of novel pyrazolopyrimidine-based derivatives as reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma. Med Chem Res, 2022, 31, 594-604.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Chalcones A-N-5

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Chalcones A-N-5 

Chalcones A-N-5 是一种三羟基查耳酮衍生物化合物。Chalcones A-N-5 在浓度低于 100 µM (IC50 > 1 mM) 时不显示细胞毒性,但对促进细胞增殖有显着作用。Chalcones A-N-5 可能促进受损脑组织中神经元细胞的生长。Chalcones A-N-5 还抑制由 RSL 或 erastin 诱导的铁死亡,并降低由 Aβ1-42 蛋白聚集诱导的脂质过氧化水平。Chalcones A-N-5 是一种很有前途的分子骨架候选物,可用于进一步开发用于体内试验的先导化合物以研究 AD。

Chalcones A-N-5

Chalcones A-N-5 Chemical Structure

CAS No. : 2756846-09-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Chalcones A-N-5 is a trihydroxy chalcone derivative compound. Chalcones A-N-5 doesn’t show cytotoxicity at the concentration lower than 100 µM (with IC50 > 1 mM), but has a significant effect on promoting cell proliferation. Chalcones A-N-5 potentially promotes neuronal cell growth in the damaged brain tissue. Chalcones A-N-5 also inhibits ferroptosis induced by RSL or erastin and reduces the lipid peroxidation levels induced by Aβ1-42 protein aggregation. Chalcones A-N-5 is a promising molecular skeleton candidate for further development of lead compound for in vivo test to research AD[1].

分子量

392.41

Formula

C21H20N4O4

CAS 号

2756846-09-8

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Liu Y, et al. Rational design, synthesis and activities of hydroxylated chalcones as highly potent dual functional agents against Alzheimer’s disease. Bioorg Chem. 2022;122:105662.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

BTK-IN-9

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

BTK-IN-9 

BTK-IN-9 是一种可逆的 BTK 抑制剂,在套细胞淋巴瘤细胞中中具有较强的抗增殖活性。BTK-IN-9 特异性地扰乱线粒体膜电位并增加 Z138 细胞中的活性氧水平。BTK-IN-9 还诱导 Z138 细胞中的细胞凋亡。

BTK-IN-9

BTK-IN-9 Chemical Structure

CAS No. : 2361192-21-2

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

BTK-IN-9 is a reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma. BTK-IN-9 specifically disturbs mitochondrial membrane potential and increases reactive oxygen species level in Z138 cells. BTK-IN-9 also induces cell apoptosis in Z138 cells[1].

分子量

481.46

Formula

C25H19N7O4

CAS 号

2361192-21-2

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Ran F, et al. Design and synthesis of novel pyrazolopyrimidine-based derivatives as reversible BTK inhibitors with potent antiproliferative activity in mantle cell lymphoma. Med Chem Res, 2022, 31, 594-604.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Chalcones A-N-5

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Chalcones A-N-5 

Chalcones A-N-5 是一种三羟基查耳酮衍生物化合物。Chalcones A-N-5 在浓度低于 100 µM (IC50 > 1 mM) 时不显示细胞毒性,但对促进细胞增殖有显着作用。Chalcones A-N-5 可能促进受损脑组织中神经元细胞的生长。Chalcones A-N-5 还抑制由 RSL 或 erastin 诱导的铁死亡,并降低由 Aβ1-42 蛋白聚集诱导的脂质过氧化水平。Chalcones A-N-5 是一种很有前途的分子骨架候选物,可用于进一步开发用于体内试验的先导化合物以研究 AD。

Chalcones A-N-5

Chalcones A-N-5 Chemical Structure

CAS No. : 2756846-09-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Chalcones A-N-5 is a trihydroxy chalcone derivative compound. Chalcones A-N-5 doesn’t show cytotoxicity at the concentration lower than 100 µM (with IC50 > 1 mM), but has a significant effect on promoting cell proliferation. Chalcones A-N-5 potentially promotes neuronal cell growth in the damaged brain tissue. Chalcones A-N-5 also inhibits ferroptosis induced by RSL or erastin and reduces the lipid peroxidation levels induced by Aβ1-42 protein aggregation. Chalcones A-N-5 is a promising molecular skeleton candidate for further development of lead compound for in vivo test to research AD[1].

分子量

392.41

Formula

C21H20N4O4

CAS 号

2756846-09-8

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Liu Y, et al. Rational design, synthesis and activities of hydroxylated chalcones as highly potent dual functional agents against Alzheimer’s disease. Bioorg Chem. 2022;122:105662.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Chalcones A-N-5

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Chalcones A-N-5 

Chalcones A-N-5 是一种三羟基查耳酮衍生物化合物。Chalcones A-N-5 在浓度低于 100 µM (IC50 > 1 mM) 时不显示细胞毒性,但对促进细胞增殖有显着作用。Chalcones A-N-5 可能促进受损脑组织中神经元细胞的生长。Chalcones A-N-5 还抑制由 RSL 或 erastin 诱导的铁死亡,并降低由 Aβ1-42 蛋白聚集诱导的脂质过氧化水平。Chalcones A-N-5 是一种很有前途的分子骨架候选物,可用于进一步开发用于体内试验的先导化合物以研究 AD。

Chalcones A-N-5

Chalcones A-N-5 Chemical Structure

CAS No. : 2756846-09-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Chalcones A-N-5 is a trihydroxy chalcone derivative compound. Chalcones A-N-5 doesn’t show cytotoxicity at the concentration lower than 100 µM (with IC50 > 1 mM), but has a significant effect on promoting cell proliferation. Chalcones A-N-5 potentially promotes neuronal cell growth in the damaged brain tissue. Chalcones A-N-5 also inhibits ferroptosis induced by RSL or erastin and reduces the lipid peroxidation levels induced by Aβ1-42 protein aggregation. Chalcones A-N-5 is a promising molecular skeleton candidate for further development of lead compound for in vivo test to research AD[1].

分子量

392.41

Formula

C21H20N4O4

CAS 号

2756846-09-8

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Liu Y, et al. Rational design, synthesis and activities of hydroxylated chalcones as highly potent dual functional agents against Alzheimer’s disease. Bioorg Chem. 2022;122:105662.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

GRPR antagonist-1

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

GRPR antagonist-1 

GRPR antagonist-1 是一种有效的胃泌素释放肽受体 (GRPR) 拮抗剂,对某些癌细胞具有细胞毒性 (在PC3、Pan02、HGC-27 细胞中的 IC50 分别是 4.97、4.36、3.40 μM)。GRPR antagonist-1 通过降低 Bcl-2 水平、增加 Bax 水平,来抑制 HGC-27 细胞活力,引起细胞凋亡。具有抗癌活性。

GRPR antagonist-1

GRPR antagonist-1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

GRPR antagonist-1 is a potent gastrin releasing peptide receptor (GRPR) antagonist, having the cytotoxicity against certain cancer cells (IC50 of 4.97, 4.36 and 3.40 μM in PC3, Pan02 and HGC-27 cells, respectively). GRPR antagonist-1 inhibits HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis. Anticancer activity[1].

IC50 & Target

IC50: 4.97 μM (GRPR) in PC3, 4.36 μM (GRPR) in Pan02, 3.40 μM (GRPR) in HGC-27[1]

体外研究
(In Vitro)

GRPR antagonist-1 (compound 5a) (0.032-100 μM; 48 hours) has the cytotoxicity against certain cancer cells, also reduces PC3, Pan02, HGC-27, and HepG2 cell viability combined with HDAC inhibitor (1 μM)[1].
GRPR antagonist-1 (1, 2, 8 μM; 24 hours) increases the rate of late apoptosis/necrosis, inducing apoptosis of HGC-27 cells[1].
GRPR antagonist-1 (0.8, 4 μM; 24 hours) inhibits HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay

Cell Line: PC3, HepG2, HGC-27, Pan02, and HK2 cells[1]
Concentration: 0.032-100 μM
Incubation Time: 48 hours
Result: Showed the cytotoxicity against these cancer cells, also reduced PC3, Pan02, HGC-27, and HepG2 cell viability combined with HDAC inhibitor (1 μM).

Apoptosis Analysis

Cell Line: HGC-27[1]
Concentration: 1, 2, 8 μM
Incubation Time: 24 hours
Result: Increased the rate of late apoptosis/necrosis, inducing apoptosis of HGC-27 cells.

Western Blot Analysis

Cell Line: HGC-27[1]
Concentration: 0.8, 4 μM
Incubation Time: 24 hours
Result: Inhibited HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis.

分子量

558.59

Formula

C29H33F3N4O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Yu, Mj., et al. Structure–activity relationship studies on Pd176252 derivatives leading to discovery of novel GRP receptor antagonist with potent anticancer activity. Med Chem Res 30, 2069–2089 (2021).

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

GRPR antagonist-1

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

GRPR antagonist-1 

GRPR antagonist-1 是一种有效的胃泌素释放肽受体 (GRPR) 拮抗剂,对某些癌细胞具有细胞毒性 (在PC3、Pan02、HGC-27 细胞中的 IC50 分别是 4.97、4.36、3.40 μM)。GRPR antagonist-1 通过降低 Bcl-2 水平、增加 Bax 水平,来抑制 HGC-27 细胞活力,引起细胞凋亡。具有抗癌活性。

GRPR antagonist-1

GRPR antagonist-1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

GRPR antagonist-1 is a potent gastrin releasing peptide receptor (GRPR) antagonist, having the cytotoxicity against certain cancer cells (IC50 of 4.97, 4.36 and 3.40 μM in PC3, Pan02 and HGC-27 cells, respectively). GRPR antagonist-1 inhibits HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis. Anticancer activity[1].

IC50 & Target

IC50: 4.97 μM (GRPR) in PC3, 4.36 μM (GRPR) in Pan02, 3.40 μM (GRPR) in HGC-27[1]

体外研究
(In Vitro)

GRPR antagonist-1 (compound 5a) (0.032-100 μM; 48 hours) has the cytotoxicity against certain cancer cells, also reduces PC3, Pan02, HGC-27, and HepG2 cell viability combined with HDAC inhibitor (1 μM)[1].
GRPR antagonist-1 (1, 2, 8 μM; 24 hours) increases the rate of late apoptosis/necrosis, inducing apoptosis of HGC-27 cells[1].
GRPR antagonist-1 (0.8, 4 μM; 24 hours) inhibits HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay

Cell Line: PC3, HepG2, HGC-27, Pan02, and HK2 cells[1]
Concentration: 0.032-100 μM
Incubation Time: 48 hours
Result: Showed the cytotoxicity against these cancer cells, also reduced PC3, Pan02, HGC-27, and HepG2 cell viability combined with HDAC inhibitor (1 μM).

Apoptosis Analysis

Cell Line: HGC-27[1]
Concentration: 1, 2, 8 μM
Incubation Time: 24 hours
Result: Increased the rate of late apoptosis/necrosis, inducing apoptosis of HGC-27 cells.

Western Blot Analysis

Cell Line: HGC-27[1]
Concentration: 0.8, 4 μM
Incubation Time: 24 hours
Result: Inhibited HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis.

分子量

558.59

Formula

C29H33F3N4O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Yu, Mj., et al. Structure–activity relationship studies on Pd176252 derivatives leading to discovery of novel GRP receptor antagonist with potent anticancer activity. Med Chem Res 30, 2069–2089 (2021).

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

GRPR antagonist-1

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

GRPR antagonist-1 

GRPR antagonist-1 是一种有效的胃泌素释放肽受体 (GRPR) 拮抗剂,对某些癌细胞具有细胞毒性 (在PC3、Pan02、HGC-27 细胞中的 IC50 分别是 4.97、4.36、3.40 μM)。GRPR antagonist-1 通过降低 Bcl-2 水平、增加 Bax 水平,来抑制 HGC-27 细胞活力,引起细胞凋亡。具有抗癌活性。

GRPR antagonist-1

GRPR antagonist-1 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

GRPR antagonist-1 is a potent gastrin releasing peptide receptor (GRPR) antagonist, having the cytotoxicity against certain cancer cells (IC50 of 4.97, 4.36 and 3.40 μM in PC3, Pan02 and HGC-27 cells, respectively). GRPR antagonist-1 inhibits HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis. Anticancer activity[1].

IC50 & Target

IC50: 4.97 μM (GRPR) in PC3, 4.36 μM (GRPR) in Pan02, 3.40 μM (GRPR) in HGC-27[1]

体外研究
(In Vitro)

GRPR antagonist-1 (compound 5a) (0.032-100 μM; 48 hours) has the cytotoxicity against certain cancer cells, also reduces PC3, Pan02, HGC-27, and HepG2 cell viability combined with HDAC inhibitor (1 μM)[1].
GRPR antagonist-1 (1, 2, 8 μM; 24 hours) increases the rate of late apoptosis/necrosis, inducing apoptosis of HGC-27 cells[1].
GRPR antagonist-1 (0.8, 4 μM; 24 hours) inhibits HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay

Cell Line: PC3, HepG2, HGC-27, Pan02, and HK2 cells[1]
Concentration: 0.032-100 μM
Incubation Time: 48 hours
Result: Showed the cytotoxicity against these cancer cells, also reduced PC3, Pan02, HGC-27, and HepG2 cell viability combined with HDAC inhibitor (1 μM).

Apoptosis Analysis

Cell Line: HGC-27[1]
Concentration: 1, 2, 8 μM
Incubation Time: 24 hours
Result: Increased the rate of late apoptosis/necrosis, inducing apoptosis of HGC-27 cells.

Western Blot Analysis

Cell Line: HGC-27[1]
Concentration: 0.8, 4 μM
Incubation Time: 24 hours
Result: Inhibited HGC-27 cell viability by decreasing the Bcl-2 level and increasing the Bax level, causing apoptosis.

分子量

558.59

Formula

C29H33F3N4O4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Yu, Mj., et al. Structure–activity relationship studies on Pd176252 derivatives leading to discovery of novel GRP receptor antagonist with potent anticancer activity. Med Chem Res 30, 2069–2089 (2021).

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

JYD-1800智能型超声波细胞破碎仪(超声波细胞粉碎机)

【简单介绍】

JYD-1800智能型超声波细胞破碎仪(超声波细胞粉碎机),1800W,设计精良、外型美观、操作简便、工作稳定、性能可靠。采用单片机控制技术和锁相环频率自动跟踪,具有超声波发射功率超载自动调整和超温保护及报警功能,可存储10套程序数据,掉电数据保存可达100年。

【详细说明】

JYD-1800智能型超声波细胞破碎仪(超声波细胞粉碎机)

产品简述 
   JYD-1800智能型超声波细胞破碎仪(超声波细胞粉碎机)采用来自德国技术、国内超声波细胞粉碎机升级换代产品,其设计精良、外型美观、操作简便、工作稳定、性能可靠。采用单片机控制技术和锁相环频率自动跟踪,具有超声波发射功率超载自动调整和超温保护及报警功能,可存储10套程序数据,掉电数据保存可达100年。 

产品参数 

1.功率:1800W

2.随机变幅杆:φ15

3.可选变幅杆:φ15、20、25

4.破碎容量:550-1200ml

5.工作次数:0-99次(可调)

6.超声时间:0-99秒(可调)

7.间隙时间:0-99秒(可调)

8.功率调整:额定功率的0-99%

9.温度设定范围:0-99℃

10.时间控制精度:1S±0.1%

11.温度控制精度:±1℃

12.占空比:见表

13.工作电压:220VAC±5%.50Hz

14.工作环境温度:0-55℃

15.相对湿度:≤85%

16.大气压力:86-106Kpa

17.主机重量:10Kg

18.主机体积:357×304×145MM(型号不同,有差别)


应用领域 
    是一种利用超声波在液体中产生空化效应的多功能、多用途仪器;用于各种动植物细胞、病毒细胞、细菌及组织的破碎,同时可用来乳化、分离、匀化、提取、消泡清洗及加速化学反应等。该机已被广泛用于生物化学、微生物学、药理学、物理学、动物学、农学、医学、制药等领域的教学、科研、生产。目前已在德国、美国实验室应用。 

可以开具发票,质保1年,含运费

型号

功率

随机ф

可选变辐杆ф

破碎容量ML

占空比

电源(V)

JYD-150

150

6

2、3、6、8

0.5-100

0.1-99.9

220V

JYD-250

250

6

3、6、8、10

0.5-200

0.1-99.9

220V

JYD-650

650

6或8

2、3、6、8、10、15

0.5-500

0.1-99.9

220V

JYD-900

900

10

2、3、6、8、15、20

0.5-600

0.1-99.9

220V

JYD-1200

1200

15或20

10、15、20、25

50-1000

0.1-99.9

220V

JYD-1800

1800

25

15、20、25

550-1200

0.1-99.9

220V

 

JYD-150智能型超声波细胞破碎仪(超声波细胞粉碎机)

【产品创新点】

1

【简单介绍】

JYD-150智能型超声波细胞破碎仪(超声波细胞粉碎机),150W,设计精良、外型美观、操作简便、工作稳定、性能可靠。采用单片机控制技术和锁相环频率自动跟踪,具有超声波发射功率超载自动调整和超温保护及报警功能,可存储10套程序数据,掉电数据保存可达100年。

【详细说明】

JYD-150智能型超声波细胞破碎仪(超声波细胞粉碎机)

产品简述 
   JYD-150智能型超声波细胞破碎仪(超声波细胞粉碎机)采用来自德国技术、国内超声波细胞粉碎机升级换代产品,其设计精良、外型美观、操作简便、工作稳定、性能可靠。采用单片机控制技术和锁相环频率自动跟踪,具有超声波发射功率超载自动调整和超温保护及报警功能,可存储10套程序数据,掉电数据保存可达100年。 

产品参数 

1.功率:150W

2.随机变幅杆:φ6

3.可选变幅杆:φ3、6、8、2

4.破碎容量:0.5-100ml

5.工作次数:0-99次(可调)

6.超声时间:0-99秒(可调)

7.间隙时间:0-99秒(可调)

8.功率调整:额定功率的0-99%

9.温度设定范围:0-99℃

10.时间控制精度:1S±0.1%

11.温度控制精度:±1℃

12.占空比:见表

13.工作电压:220VAC±5%.50Hz

14.工作环境温度:0-55℃

15.相对湿度:≤85%

16.大气压力:86-106Kpa

17.主机重量:10Kg

18.主机体积:357×304×145MM(型号不同,有差别)


应用领域 
    是一种利用超声波在液体中产生空化效应的多功能、多用途仪器;用于各种动植物细胞、病毒细胞、细菌及组织的破碎,同时可用来乳化、分离、匀化、提取、消泡清洗及加速化学反应等。该机已被广泛用于生物化学、微生物学、药理学、物理学、动物学、农学、医学、制药等领域的教学、科研、生产。目前已在德国、美国实验室应用。 


可以开具发票,质保1年,含运费

型号

功率

随机ф

可选变辐杆ф

破碎容量ML

占空比

电源(V)

JYD-150

150

6

2、3、6、8

0.5-100

0.1-99.9

220V

JYD-250

250

6

3、6、8、10

0.5-200

0.1-99.9

220V

JYD-650

650

6或8

2、3、6、8、10、15

0.5-500

0.1-99.9

220V

JYD-900

900

10

2、3、6、8、15、20

0.5-600

0.1-99.9

220V

JYD-1200

1200

15或20

10、15、20、25

50-1000

0.1-99.9

220V

JYD-1800

1800

25

15、20、25

550-1200

0.1-99.9

220V

 

Apaziquone(Synonyms: EO-9; NSC 382 459)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Apaziquone (Synonyms: EO-9; NSC 382 459)

Apaziquone (EO-9) 是丝裂霉素 C (Mitomycin C) 的类似物,是一种前药,可被氧化还原酶(尤其是 NQO1) 激活产生 DNA 损伤。Apaziquone 具有杀死需氧和/或缺氧癌细胞的能力。Apaziquone 是一种生物还原性烷化剂,可抑制口腔鳞状细胞癌 (OSCC) 细胞的细胞增殖并诱导细胞凋亡。Apaziquone 显着减少免疫功能低下的 NOD/SCID/Crl 小鼠的口腔肿瘤异种移植物体积。

Apaziquone(Synonyms: EO-9;  NSC 382 459)

Apaziquone Chemical Structure

CAS No. : 114560-48-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Apaziquone (EO-9), an analog of Mitomycin C, is a prodrug that is activated to DNA damaging species by oxidoreductases (particularly NQO1). Apaziquone has the ability to kill aerobic and/or hypoxic cancer cells. Apaziquone, a bioreductive alkylating agent, inhibits cell proliferation and induces apoptosis in oral squamous cell carcinoma (OSCC) cells. Apaziquone significantly reduces oral tumor xenograft volume in immunocompromised NOD/SCID/Crl mice[1][2].

分子量

288.30

Formula

C15H16N2O4

CAS 号

114560-48-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Gunjan Srivastava, et al. Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy. PLoS One. 2015 Jul 24;10(7):e0133735.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Apaziquone(Synonyms: EO-9; NSC 382 459)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Apaziquone (Synonyms: EO-9; NSC 382 459)

Apaziquone (EO-9) 是丝裂霉素 C (Mitomycin C) 的类似物,是一种前药,可被氧化还原酶(尤其是 NQO1) 激活产生 DNA 损伤。Apaziquone 具有杀死需氧和/或缺氧癌细胞的能力。Apaziquone 是一种生物还原性烷化剂,可抑制口腔鳞状细胞癌 (OSCC) 细胞的细胞增殖并诱导细胞凋亡。Apaziquone 显着减少免疫功能低下的 NOD/SCID/Crl 小鼠的口腔肿瘤异种移植物体积。

Apaziquone(Synonyms: EO-9;  NSC 382 459)

Apaziquone Chemical Structure

CAS No. : 114560-48-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Apaziquone (EO-9), an analog of Mitomycin C, is a prodrug that is activated to DNA damaging species by oxidoreductases (particularly NQO1). Apaziquone has the ability to kill aerobic and/or hypoxic cancer cells. Apaziquone, a bioreductive alkylating agent, inhibits cell proliferation and induces apoptosis in oral squamous cell carcinoma (OSCC) cells. Apaziquone significantly reduces oral tumor xenograft volume in immunocompromised NOD/SCID/Crl mice[1][2].

分子量

288.30

Formula

C15H16N2O4

CAS 号

114560-48-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Gunjan Srivastava, et al. Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy. PLoS One. 2015 Jul 24;10(7):e0133735.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Apaziquone(Synonyms: EO-9; NSC 382 459)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Apaziquone (Synonyms: EO-9; NSC 382 459)

Apaziquone (EO-9) 是丝裂霉素 C (Mitomycin C) 的类似物,是一种前药,可被氧化还原酶(尤其是 NQO1) 激活产生 DNA 损伤。Apaziquone 具有杀死需氧和/或缺氧癌细胞的能力。Apaziquone 是一种生物还原性烷化剂,可抑制口腔鳞状细胞癌 (OSCC) 细胞的细胞增殖并诱导细胞凋亡。Apaziquone 显着减少免疫功能低下的 NOD/SCID/Crl 小鼠的口腔肿瘤异种移植物体积。

Apaziquone(Synonyms: EO-9;  NSC 382 459)

Apaziquone Chemical Structure

CAS No. : 114560-48-4

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Apaziquone (EO-9), an analog of Mitomycin C, is a prodrug that is activated to DNA damaging species by oxidoreductases (particularly NQO1). Apaziquone has the ability to kill aerobic and/or hypoxic cancer cells. Apaziquone, a bioreductive alkylating agent, inhibits cell proliferation and induces apoptosis in oral squamous cell carcinoma (OSCC) cells. Apaziquone significantly reduces oral tumor xenograft volume in immunocompromised NOD/SCID/Crl mice[1][2].

分子量

288.30

Formula

C15H16N2O4

CAS 号

114560-48-4

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Gunjan Srivastava, et al. Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer Therapy. PLoS One. 2015 Jul 24;10(7):e0133735.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

美国Crystal电热细胞恒温培养箱PY-30/PY-16

【简单介绍】

美国Crystal电热细胞恒温培养箱PY-30/PY-16,是专为使用细胞转瓶培养器培养细胞而配套设计、生产的恒温箱,它们为细胞生长提供了温度可调的培养空间,对于小批量的试验、生产来说,比建造恒温室节省空间和能源。

【详细说明】

美国Crystal电热细胞恒温培养箱PY-30/PY-16

产品描述

     美国Crystal电热细胞恒温培养箱PY-30/PY-16是专为使用细胞转瓶培养器培养细胞而配套设计、生产的恒温箱,它们为细胞生长提供了温度可调的培养空间,对于小批量的试验、生产来说,比建造恒温室节省空间和能源。除了为大批量细胞生产而设计的超大型细胞转瓶培养器外,对应型号的细胞转瓶培养器均可整机放入恒温箱内使用。PID程序的自动温度控制和双壁隔热层设计,使温度控制更精确、稳定。内壁采用镜面不锈钢,使得清洗更为方便。

   Crystal CellRoller? 细胞转瓶培养器/恒温箱适用于悬浮培养和贴壁培养两种主要的细胞培养方式。有电热恒温培养箱和CO2恒温培养箱供配套选择。细胞转瓶培养器通过转速的调节,满足悬浮或贴壁培养细胞的条件。它能有效地增加细胞培养的面积、促进细胞与气体的交换,有利于细胞生长和收集,大大提高细胞培养的产量,是实验室细胞培养、生物制药小试、中试及批量生产的理想设备。


技术特点

1. 采用微处理芯片,性能稳定;

2. 采用高精度传感器和PID控制,控温准确;

3. 超温声光报警、自动断电, 安全可靠;

4. LED数字显示、触摸开关、操作简便易行;

5. 采用*的气流循环技术、腔室温度均匀;

6. 外观设计简洁大方, 美观且实用。


技术参数

型号 PY-16 PY-30 PYC-16 PYC-30
温度显示 数字显示
温控范围 环境温度+5℃~60℃(环境温度5℃~40℃)
控制精度 0.1℃
温度均匀度 ±0.5℃(环境温度25℃,设定值37℃,5%空载)
温度波动度 ±0.2℃(环境温度25℃,设定值37℃,5%空载)
CO2浓度显示 数字显示
CO2浓度控制范围 0~20%
CO2浓度控制精度 0.1%(at 5%)
CO2浓度恢复到5% <10分钟
CO2传感器 红外
工作电源 AC220V 50Hz
大功耗 1250W
内部尺寸 745×690×1115mm 870×690×1480mm 745×690×1115mm 870×690×1480mm
外形尺寸 845×885×1349mm 970×885×1716mm 845×885×1349mm 970×885×1716mm
内壁 镜面不锈钢
箱门 中空玻璃门
报警功能 超温报警、温度传感器异常报警、独立的过热保护、CO2浓度报警
重量 175kg 195kg 175kg 195kg




附件

名称 型号 备注 适用机型 图片
5层隔板架及钢丝小托盘 PY-16-S1 标配2个托盘,多放5个托盘 PYC-16
8层隔板架及钢丝托盘 PY-30-S3 标配3个托盘,多放8个托盘 PYC-30
紫外灯附件 PY-30-S4 / PYC-16 PYC-30
水平摇床支架组件 PY-30-S2 可放2台水平摇床,2块PY-30-S5,底层可放加湿盘,可放5L烧瓶。 PYC-30
PY-30-S7 可放3台水平摇床 PYC-30
钢丝托盘 PY-30-S5 与8层隔板架配套使用 PYC-30
小钢丝托盘 PY-16-S2 与5层隔板架配套使用 PYC-16


细胞松弛素D

细胞松弛素D

曼氏接合孢子菌制备的现成溶液,5mg/mL in DMSO

有货

细胞松弛素D

CAS编号 22144-77-0 | 品牌:Jinpan
Cytochalasin D

MSDS

质检证书(CoA)

相似产品

  • 分子式 C30H37NO6
  • 分子量507.62
  • Beilstein号 1632828
  • EC号 244-804-1
  • MDL号 MFCD00077706
  • PubChem编号 122173078

货号 (SKU) 包装规格 是否现货 价格 数量
C477743-200μl 200μL 期货 细胞松弛素D  

基本信息

产品名称 细胞松弛素D
英文名称 Cytochalasin D
英文别名 Zygosporin A
规格或纯度 曼氏接合孢子菌制备的现成溶液,5mg/mL in DMSO
运输条件 超低温冰袋运输

一般描述

Description

Cytochalasin B is used to inhibit sugar transport in fibroblasts , decrease cytoskeletal actin and myosin in rabbit neutrophils , and to stimulate B lymphocytes . It is a potent inhibitor of actin polymerization, disrupts actin microfilaments, activates the p53-dependent pathways, inhibits smooth muscle contraction, and inhibits insulin-stimulated glucose transport.

Description

Cytochalasin B is used to inhibit sugar transport in fibroblasts , decrease cytoskeletal actin and myosin in rabbit neutrophils , and to stimulate B lymphocytes . It is a potent inhibitor of actin polymerization, disrupts actin microfilaments, activates the p53-dependent pathways, inhibits smooth muscle contraction, and inhibits insulin-stimulated glucose transport.

相关属性

CAS编号 22144-77-0
储存温度 -20°C储存
RTECS GZ4850000
MDL号 MFCD00077706
分子量 507.62
分子式 C30H37NO6
EC号 244-804-1
品牌 Jinpan
PubChem CID 122173078

Isatuximab

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Isatuximab 

Isatuximab 是一种单克隆抗体,靶向跨膜受体和胞外酶 CD38,一种在血液系统恶性细胞,包括多发性骨髓瘤中高度表达的蛋白。Isatuximab 通过多种生物学机制具有抗肿瘤活性,包括抗体依赖性细胞介导的细胞毒性、补体依赖性细胞毒性、抗体依赖性细胞吞噬作用和无交联直接诱导细胞凋亡 (apoptosis)。Isatuximab 还直接抑制 CD38 胞外酶活性,这与许多细胞功能有关。

Isatuximab

Isatuximab Chemical Structure

CAS No. : 1461640-62-9

规格 价格 是否有货
1 mg ¥3500 询问价格 & 货期
5 mg ¥8600 询问价格 & 货期
10 mg ¥14500 询问价格 & 货期

* Please select Quantity before adding items.

生物活性

Isatuximab is a monoclonal antibody targeting the transmembrane receptor and ectoenzyme CD38, a protein highly expressed on hematological malignant cells, including those in multiple myeloma (MM). Isatuximab has antitumor activity via multiple biological mechanisms, including antibody-dependent cellular-mediated cytotoxicity, complement-dependent cytotoxicity, antibody-dependent cellular phagocytosis, and direct induction of apoptosis without crosslinking. Isatuximab also directly inhibits CD38 ectoenzyme activity, which is implicated in many cellular functions[1][2].

体外研究
(In Vitro)

An in-vitro study shows that the combination of Isatuximab with Pomalidomide (an immunomodulatory drug) results in greater direct toxicity and lysis of CD38 multiple myeloma cells by effector cells compared with Isatuximab alone[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

CAS 号

1461640-62-9

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Dhillon S. Isatuximab: First Approval [published correction appears in Drugs. 2020 May 23;:]. Drugs. 2020;80(9):905-912.

    [2]. Attal M, et al. Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study [published correction appears in Lancet. 2019 Dec 7;394(10214):2072]. Lancet. 2019;394(10214):2096-2107.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

ALK-IN-9

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

ALK-IN-9 

ALK-IN-9 (compound 40) 是一种有效的 ALK 抑制剂。ALK-IN-9 可以抑制细胞增殖,对 Ba/F3-EML4-ALK,KM 12 (TPM3-TRKA),KG-1 细胞 (OP2-FGFR1) 的 IC50 分别为 <0.2 nM,<0.2 nM,0.2 nM。

ALK-IN-9

ALK-IN-9 Chemical Structure

CAS No. : 2359662-39-6

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

ALK-IN-9 (compound 40) is a potent ALK inhibitor. ALK-IN-9 inhibits cell proliferation with IC50s of <0.2 nM, <0.2 nM, 0.2 nM for Ba/F3-EML4-ALK, KM 12 (TPM3-TRKA), KG-l cell (OP2-FGFR1), respectively[1].

分子量

412.42

Formula

C20H21FN6O3

CAS 号

2359662-39-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Evan W. ROGERS, et al. Inhibiteurs macrocycliques de kinase et leur utilisation. US20160159741A1.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Kaempferol(Synonyms: 山奈酚; Kempferol; Robigenin)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Kaempferol (Synonyms: 山奈酚; Kempferol; Robigenin) 纯度: 99.67%

Kaempferol (Kempferol) 在乳腺癌细胞中抑制雌激素受体 (estrogen receptor α) 表达,在胶质母细胞瘤细胞和肺癌细胞中,通过激活 MEK-MAPK 诱导细胞凋亡。Kaempferol 可用于乳腺癌研究。

Kaempferol(Synonyms: 山奈酚; Kempferol;  Robigenin)

Kaempferol Chemical Structure

CAS No. : 520-18-3

规格 价格 是否有货 数量
Free Sample (0.1-0.5 mg)   Apply now  
10 mM * 1 mL in DMSO ¥450 In-stock
50 mg ¥405 In-stock
100 mg ¥750 In-stock
200 mg ¥900 In-stock
500 mg ¥2000 In-stock
1 g   询价  
5 g   询价  

* Please select Quantity before adding items.

Kaempferol 相关产品

相关化合物库:

  • Natural Product Library Plus
  • Bioactive Compound Library Plus
  • Anti-Infection Compound Library
  • Apoptosis Compound Library
  • Metabolism/Protease Compound Library
  • Natural Product Library
  • Anti-Cancer Compound Library
  • Antiviral Compound Library
  • Autophagy Compound Library
  • Human Endogenous Metabolite Compound Library
  • Anti-Aging Compound Library
  • Diabetes Related Compound Library
  • Medicine Food Homology Compound Library
  • Phenols Library
  • Traditional Chinese Medicine Monomer Library
  • FDA Approved & Pharmacopeial Drug Library
  • Flavonoids Library
  • Anti-Breast Cancer Compound Library
  • Anti-Lung Cancer Compound Library
  • Antiparasitic Compound library
  • Mitochondria-Targeted Compound Library
  • Food-Sourced Compound Library

生物活性

Kaempferol (Kempferol), a flavonoid found in many edible plants, inhibits estrogen receptor α expression in breast cancer cells and induces apoptosis in glioblastoma cells and lung cancer cells by activation of MEK-MAPK. Kaempferol can be uesd for the research of breast cancer[1][2][3][4].

IC50 & Target[1]

ERα

 

Human Endogenous Metabolite

 

体外研究
(In Vitro)

Kaempferol also has anti-inflammatory effects via inhibition of interleukin-4 and cyclo-oxygenase 2 expression by suppressing Src kinase and downregulating the NFκB pathway. Kaempferol is also effective in inhibiting angiogenesis and inducing apoptosis in ovarian cancer cells[1]. Kaempferol is a natural flavonoid that is widely distributed in fruits and vegetables, and prospective studies revealed that over decades, consumption of Kaempferol dramatically and significantly reduces the risk of ovarian cancer in American female nurses. After a 24-hour treatment, Kaempferol causes a significant and concentration-dependent inhibition of proliferation in all 3 ovarian cancer cells tested. This inhibition is observed at 40 μM or higher concentrations of treatment[2]. Kaempferol is a flavonoid which is abundant in a variety of plant derived food and leaves used in traditional medicines. Kaempferol significantly inhibits NADPH oxidase activity. Kaempferol decrease reactive oxygen species (ROS) by directly bound NADPH oxidase. Kaempferol prevents Ang II-induced sinus nodal cell death by lowering CAMKII oxidization[3].10-20 μM Kaempferol dose-dependently suppresses its release in sensitized RBL-2H3 cells. When 10-20 μM Kaempferol is supplemented to DNP-BSA-challenged RBL-2H3 cells for 15 min, the activation of Syk and PLCγ is highly attenuated. When ≥10 μM Kaempferol is added to DNP-BSA-challenged RBL-2H3 cells for 60 min, the COX2 induction is reduced[4].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

The COX2 induction is confirmed in the airways of BSA-challenged BALB/c mice. There is lack of COX2 in airways of untreated control mice observed. The BSA inhalation to mice led to enhanced COX2 induction (dark brown staining) in mouse airway, which is reversed by oral administration of Kaempferol. In BSA-challenged mice, there is a marked goblet cell hyperplasia and epithelial thickening observed. When 20 mg/kg Kaempferol is supplemented to BSA-challenged mice, the epithelial thickening completely disappeared[4].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

分子量

286.24

Formula

C15H10O6

CAS 号

520-18-3

中文名称

山奈酚

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder -20°C 3 years
4°C 2 years
In solvent -80°C 6 months
-20°C 1 month
溶解性数据
In Vitro: 

DMSO : ≥ 32 mg/mL (111.79 mM)

H2O : < 0.1 mg/mL (ultrasonic;warming;heat to 60°C) (insoluble)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 3.4936 mL 17.4679 mL 34.9357 mL
5 mM 0.6987 mL 3.4936 mL 6.9871 mL
10 mM 0.3494 mL 1.7468 mL 3.4936 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2 mg/mL (6.99 mM); Clear solution

    此方案可获得 ≥ 2 mg/mL (6.99 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液

  • 2.

    请依序添加每种溶剂: 10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2 mg/mL (6.99 mM); Clear solution

    此方案可获得 ≥ 2 mg/mL (6.99 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 20.0 mg/mL 的澄清 DMSO 储备液加到 900 μL 20% 的 SBE-β-CD 生理盐水水溶液中,混合均匀。

    将 2 g 磺丁基醚 β-环糊精加入 5 mL 生理盐水中,再用生理盐水定容至 10 mL,完全溶解,澄清透明
  • 3.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2 mg/mL (6.99 mM); Clear solution

    此方案可获得 ≥ 2 mg/mL (6.99 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 20.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献
  • [1]. Luo H, et al. Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int J Nanomedicine. 2012; 7: 3951-3959.

    [2]. Luo H, et al. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem. 2011 September 15; 128(2): 513-519.

    [3]. An M, et al. Protective effects of Kaempferol against cardiac sinus node dysfunction via CaMKII deoxidization. Anat Cell Biol. 2015 Dec;48(4):235-43.

    [4]. Shin D, et al. Dietary Compound Kaempferol Inhibits Airway Thickening Induced by Allergic Reaction in a Bovine Serum Albumin-Induced Model of Asthma. Int J Mol Sci. 2015 Dec 16;16(12):29980-95.

Kinase Assay
[3]

Right atria or sinus nodal cells are homogenized in lysis buffer consisting of (50 mM Tris-HCl pH 7.5, 100 mM KCl, 1 mM ethylenediamine tetraacetic acid, 1 mM ethylene glycol tetraacetic acid, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 0.5 mM Benzamidine, 20 mg/L Leupeptin, 20 mM sodium pyrophosphate, 50 mM NaF, and 50 mM sodium β-glycerophosphate), and total protein content is determined by the Bradford assay. Caspase-3 activity is determined by EnzChek Caspase-3 Assay Kit[3].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Assay
[2]

Ovarian cancer cells are seeded in 96-well plates at 2000 cells/well and incubated overnight before treatment with 0-160 μM Kaempferol for 24 hours in triplicates. The medium is removed, and the plates are freeze-thawed to lyse cells. Each well is added with 200 μL 1× CyQUANT cell lysis buffer containing 5x SYBR Green I and incubated at room temperature (RT) for 5 minutes. The reaction (50 μL) is transferred to PCR strip tubes and the fluorescent signal is measured at 90°C with a real-time Chromo4 PCR instrument. To ensure that cell proliferation assays are performed within a linear range of cell numbers, a standard curve is generated by seeding different amount of OVCAR-3 cells (based on counting with a hemacytometer) in a 96-well plate, and measuring genomic DNA abundance after overnight incubation. Three independent experiments are performed and data is pooled for statistical analysis[2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Administration
[4]

Mice[4]
Three-week-old male BALB/c mice are randomly assigned to the four treatment groups as follows (n=8 per group). (1) PBS-sensitized mice; (2) BSA-sensitized mice; (3) BSA-sensitized and 10 mg/kg Kaempferol-administered mice; and (4) BSA-sensitized and 20 mg/kg Kaempferol-administered mice. Mice are given a commercial mouse chow diet containing 20.5% protein, 3.5% fat, 8% fiber, 8% ash, and 0.5% phosphorus and are allowed access to food and water ad libitum. The mice are kept under a 12 h light and dark cycle at 23±1°C with 50%±5% relative humidity in specific pathogen-free conditions. Mice are allowed to become accustomed to their surroundings for one week before starting the allergic experiments. Sensitization of all experimental mice is carried out by subcutaneous injection with 20 μg BSA in 30 μL PBS and 50 μL Imject Alum on days 0 and 14. The control mice are injected with a combination of 50 μL PBS and 50 μL Imject Alum without BSA. On days 28, 29, and 30, only the experimental mice sensitized to BSA are subject to inhalation of 5% BSA, while control mice are challenged with 5% PBS for 20 min in a plastic chamber connected to a Medel aerosol nebulizer. All mice are sacrificed 24 h after the last challenge. Whole blood samples are directly used to measure the contents of eosinophils, basophils and neutrophils. The right lung is stored in 4% paraformaldehyde until use.

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

参考文献
  • [1]. Luo H, et al. Kaempferol nanoparticles achieve strong and selective inhibition of ovarian cancer cell viability. Int J Nanomedicine. 2012; 7: 3951-3959.

    [2]. Luo H, et al. Kaempferol induces apoptosis in ovarian cancer cells through activating p53 in the intrinsic pathway. Food Chem. 2011 September 15; 128(2): 513-519.

    [3]. An M, et al. Protective effects of Kaempferol against cardiac sinus node dysfunction via CaMKII deoxidization. Anat Cell Biol. 2015 Dec;48(4):235-43.

    [4]. Shin D, et al. Dietary Compound Kaempferol Inhibits Airway Thickening Induced by Allergic Reaction in a Bovine Serum Albumin-Induced Model of Asthma. Int J Mol Sci. 2015 Dec 16;16(12):29980-95.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

CGⅠ-06-F小瓶位贴壁培养细胞转瓶机系列(适用于1500ml培养瓶)

【简单介绍】

CGⅠ-06-F小瓶位贴壁培养细胞转瓶机系列(适用于1500ml培养瓶)适合实验室小试规模的细胞培养,产品可以放入常规二氧化碳培养箱中,省去采购大培养箱或者建造恒温室的费用。

【详细说明】

美国Crystal CGⅠ-06-F小瓶位贴壁培养细胞转瓶机系列(适用于1500ml培养瓶)

产品描述

  CGⅠ-06-F小瓶位贴壁培养细胞转瓶机系列(适用于1500ml培养瓶)适用于悬浮培养和贴壁培养两种主要的细胞培养方式。有电热恒温培养箱和CO2恒温培养箱供配套选择。细胞转瓶培养器通过转速的调节,满足悬浮或贴壁培养细胞的条件。它能有效地增加细胞培养的面积、促进细胞与气体的交换,有利于细胞生长和收集,大大提高细胞培养的产量,是实验室细胞培养、生物制药小试、中试及批量生产的理想设备。

 适合实验室小试规模的细胞培养,产品可以放入常规二氧化碳培养箱中,省去采购大培养箱或者建造恒温室的费用。

技术参数

细胞培养类型 贴壁培养 悬浮培养
型号 CGⅠ-06-F CG-06-F
瓶转速 3~60r/h(细胞培养瓶在Φ110mm时) 60~900r/h(细胞培养瓶在Φ110mm时)
转动方式 单向正转/单向反转/双向交替正反转(角度10°~180°可调)
适用瓶范围 Φ100mm~Φ113mm,L≤285mm
标准瓶:Φ110mm,L=285mm(1500ml)
每层瓶位数(个) 3
瓶位数(个) 6
材料 铝合金
数码控制显示功能 瓶转速显示/换向角度显示/运行时间显示
保险丝 4A 250V
通讯接口 RS 485
功率 70W
环境温度 5℃~70℃
相对湿度 <90%
外形尺寸(mm) 450×360×431.5
大负载(kg) 10
净重(kg) 22
电源 AC220V±22V 50Hz±1Hz

特点

1、LED数字显示;

2、无刷电机或步进电机驱动,使用寿命长、噪音低;

3、无油轴承,清洁无污染;

4、特种滚轮,无异味,不掉渣,耐腐蚀,耐臭氧,运行平稳;

5、多种转动模式、多种转速、操作灵活;

6、全主动轮设计,避免培养瓶打滑;

7、人性化瓶挡轮设计具有限位功能,且方便取放瓶;

8、可放入恒温培养箱内使用;

9、双列停转报警。

Calcimycin(Synonyms: A-23187; Antibiotic A-23187)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Calcimycin (Synonyms: A-23187; Antibiotic A-23187) 纯度: 99.56%

Calcimycin (A-23187) 是一种抗生素和独特的二价阳离子离子载体 (divalent cation ionophore),如钙离子和镁离子。Calcimycin 通过增加细胞内钙浓度诱导 Ca2+ 依赖性细胞死亡。Calcimycin 抑制革兰氏阳性细菌和一些真菌的生长,还抑制 ATP 酶的活性并解耦哺乳动物细胞的氧化磷酸化 (OXPHOS),诱导细胞凋亡。

Calcimycin(Synonyms: A-23187;  Antibiotic A-23187)

Calcimycin Chemical Structure

CAS No. : 52665-69-7

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ¥3253 In-stock
1 mg ¥950 In-stock
5 mg ¥2800 In-stock
10 mg   询价  
50 mg   询价  

* Please select Quantity before adding items.

Calcimycin 相关产品

相关化合物库:

  • Covalent Screening Library Plus
  • Natural Product Library Plus
  • Drug Repurposing Compound Library Plus
  • Clinical Compound Library Plus
  • Bioactive Compound Library Plus
  • Anti-Infection Compound Library
  • Apoptosis Compound Library
  • Natural Product Library
  • Anti-Cancer Compound Library
  • Clinical Compound Library
  • Autophagy Compound Library
  • Drug Repurposing Compound Library
  • Covalent Screening Library
  • Antifungal Compound Library
  • Antibacterial Compound Library
  • Antibiotics Library
  • Microbial Metabolite Library

生物活性

Calcimycin (A-23187) is an antibiotic and a unique divalent cation ionophore (like calcium and magnesium). Calcimycin induces Ca2+-dependent cell death by increasing intracellular calcium concentration. Calcimycin inhibits the growth of Gram-positive bacteria and some fungi. Calcimycin also inhibits the activity of ATPase and uncouples oxidative phosphorylation (OXPHOS) of mammalian cells. Calcimycin induces apoptosis[1][2][3][4].

体外研究
(In Vitro)

Calcimycin (A-23187) mediates mycobacterial killing by inducing intracellular calcium-regulated autophagy in a P2RX7 dependent manner[4].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Calcimycin (A-23187) (2.5 or 7.5 nM; intrapleurally) induces protein leakage[5].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mice (ICR, 25-30 g)[5]
Dosage: 2.5 or 7.5 nM
Administration: Intrapleurally
Result: Two hours after 2.5 nM, or three hours after 7.5 nM, challenge the protein levels in the pleural cavity were equivalent to about a half of their corresponding peak values.

Clinical Trial

分子量

523.62

Formula

C29H37N3O6

CAS 号

52665-69-7

中文名称

卡西霉素

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

DMSO : 33.33 mg/mL (63.65 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.9098 mL 9.5489 mL 19.0978 mL
5 mM 0.3820 mL 1.9098 mL 3.8196 mL
10 mM 0.1910 mL 0.9549 mL 1.9098 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.5 mg/mL (4.77 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (4.77 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH₂O 中,得到澄清透明的生理盐水溶液

  • 2.

    请依序添加每种溶剂: 10% DMSO    90% corn oil

    Solubility: ≥ 2.5 mg/mL (4.77 mM); Clear solution

    此方案可获得 ≥ 2.5 mg/mL (4.77 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在 上海金畔生物科技有限公司 网站选购。
参考文献
  • [1]. Wu Q, et al. Characterization of the biosynthesis gene cluster for the pyrrole polyether antibiotic calcimycin(A23187) in Streptomyces chartreusis NRRL 3882. Antimicrob Agents Chemother. 2011 Mar;55(3):974-82.

    [2]. Elliott JI, et al. IKCa1 activity is required for cell shrinkage, phosphatidylserine translocation and death in Tlymphocyte apoptosis. EMBO Rep. 2003 Feb;4(2):189-94.

    [3]. Engedal N, et al. Modulation of intracellular calcium homeostasis blocks autophagosome formation. Autophagy. 2013 Oct;9(10):1475-90.

    [4]. Mawatwal S, et al. Calcimycin mediates mycobacterial killing by inducing intracellular calcium-regulated autophagy in a P2RX7 dependent manner. Biochim Biophys Acta Gen Subj. 2017 Dec;1861(12):3190-3200.

    [5]. Wang JP, et al. Effect of norathyriol, isolated from Tripterospermum lanceolatum, on A23187-induced pleurisy and analgesia in mice. Naunyn Schmiedebergs Arch Pharmacol. 1994 Jul;350(1):90-5.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务